Merck & Company Inc - Other Cashflows From Investing Activities

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Other-Cashflows-From-Investing-Activities" stands at 4.02 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2015.

Merck & Company Inc's third quarter result of 0.987 Billion USD for the item "Other Cashflows From Investing Activities" represents an increase of 29.19 percent compared to it's second quarter result.

Also, Merck & Company Inc's third quarter result of 0.987 Billion USD for the item "Other Cashflows From Investing Activities" represents an increase of 26.05 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Merck & Company Inc's third quarter result of 4.02 Billion USD for the item "Other Cashflows From Investing Activities" represents an increase of 5.35 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.592 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.592 Billion United States Dollars.
The 3 year change is 15.36 Billion United States Dollars.
The 5 year change is 7.29 Billion United States Dollars.
The 10 year change is -2.43 Billion United States Dollars.

The Serie's long term average value is -1.70 Billion United States Dollars. It's latest available value, on 09/30/2025, is 5.72 Billion United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is +16.33 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is -7.14 Billion.